TNF-α inhibitors for type 1 diabetes: exploring the path to a pivotal clinical trial by Bazile, Cassandra, Abdel Malik, Magdy M, Ackeifi, Courtney, Anderson, Randy L, Beck, Roy W, Donath, Marc Y, Dutta, Sanjoy, Hedrick, Joseph A, Karpen, Stephen R, Kay, Thomas W H, Marder, Thomas, Marinac, Marjana, McVean, Jennifer, Meyer, Robert, Pettus, Jeremy, Quattrin, Teresa, Verstegen, Ruud H J, Vieth, Joshua A, Latres, Esther

Get full text

Consortium-based approach to receiving an EMA qualification opinion on the use of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies by Karpen, Stephen R., Dunne, Jessica L., Frohnert, Brigitte I., Marinac, Marjana, Richard, Claudia, David, Sarah E., O’Doherty, Inish M.

Get full text

Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead by Grattoni, Alessandro, Korbutt, Gregory, Tomei, Alice A., García, Andrés J., Pepper, Andrew R., Stabler, Cherie, Brehm, Michael, Papas, Klearchos, Citro, Antonio, Shirwan, Haval, Millman, Jeffrey R., Melero-Martin, Juan, Graham, Melanie, Sefton, Michael, Ma, Minglin, Kenyon, Norma, Veiseh, Omid, Desai, Tejal A., Nostro, M. Cristina, Marinac, Marjana, Sykes, Megan, Russ, Holger A., Odorico, Jon, Tang, Qizhi, Ricordi, Camillo, Latres, Esther, Mamrak, Nicholas E., Giraldo, Jaime, Poznansky, Mark C., de Vos, Paul

Get full text

Preferences for Outcomes Among Adults with Type 1 Diabetes and Caregivers of Children with Type 1 Diabetes by Marinac, Marjana, Sutphin, Jessie, Hutton, Campbell, Klein, Kathleen, Sullivan, Sean, Mansfield, Carol

Get full text